-
Posted by
Two Blokes Jul 30 -
Filed in
Stock
-
4 views
British drugmaker GSK said on Wednesday it expects to report annual sales and profit towards the top end of its forecast range, adding that its outlook includes the impact of tariffs in place so far and expected levies on European goods.